Eli Lilly Acquires Centessa Pharmaceuticals for $6.3 Billion to Gain Narcolepsy Drug
Eli Lilly announced the acquisition of Centessa Pharmaceuticals in a deal worth at least $6.3 billion, gaining access to a promising narcolepsy treatment as part of its expansion strategy.
·1 source
